Results of Nucleos(t)ide Analog Treatment Discontinuation in Hepatitis B e-Antigen-Negative Chronic Hepatitis B: NUCSTOP Study

CONCLUSION: Despite receiving NAs suppression therapy for a long time, HBsAg loss occurs rarely. Although it was not life-threatening, most patients experienced relapses and treatment should be restarted. In our study, whether it is a coincidence that all patients with HBsAg loss are patients in whom NAs are used sequentially due to lamivudine resistance is an issue that needs to be further investigated.PMID:38454274 | PMC:PMC10837598 | DOI:10.5152/tjg.2024.23463

Source: The Turkish Journal of Gastroenterology - March 7, 2024 Category: Gastroenterology Authors: Sercan Kiremit çi Koray Ko çhan G ülseren Seven Elmas Biberci Keskin G ülay Okay Yasemin Akkoyunlu Meliha Meri ç Koç Bilge S ümbül Hakan Şentürk Source Type: research